Phase I IND-enabling studies for the amyloid-imaging peptide p5+14 (Api1832) - a novel agent for the detection of systemic amyloidosis
2018
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI